ProfileGDS5678 / 1446781_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 4% 4% 4% 4% 4% 3% 5% 4% 4% 4% 4% 3% 4% 4% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.009664
GSM967853U87-EV human glioblastoma xenograft - Control 21.99844
GSM967854U87-EV human glioblastoma xenograft - Control 32.000814
GSM967855U87-EV human glioblastoma xenograft - Control 41.967014
GSM967856U87-EV human glioblastoma xenograft - Control 51.952814
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.03113
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.072545
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.981644
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.978264
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.9974
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.989944
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.963523
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.992244
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.989344